RLYP - this stock was trading at $40 before FDA approval and now their Veltassa is officially FDA approved and trading at $24???...this is a total joke, if you ask me...and the sales will start 1st week of January :) but, i suggest you to pay attention to the month of May-2016 since the rival company's drug, ZS9's pdufa is set in May...if ZS9 gets black box warning (high chance) or CRL, the game is over!!! ($80-$100 ??? )...all in my personaly view only, of course!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.